FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022195954> ?p ?o ?g. }

• W2022195954 endingPage "1950" @default.
• W2022195954 startingPage "1946" @default.
• W2022195954 abstract "No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Dec 1999LONG-TERM FOLLOWUP OF INITIAL Ta GRADE 1 TRANSITIONAL CELL CARCINOMA OF THE BLADDER B. LEBLANC, A.J. DUCLOS, F. BÉNARD, J. CÔTÉ, L. VALIQUETTE, J.M. PAQUIN, F. MAUFFETTE, R. FAUCHER, and J.P. PERREAULT B. LEBLANCB. LEBLANC More articles by this author , A.J. DUCLOSA.J. DUCLOS More articles by this author , F. BÉNARDF. BÉNARD More articles by this author , J. CÔTÉJ. CÔTÉ More articles by this author , L. VALIQUETTEL. VALIQUETTE More articles by this author , J.M. PAQUINJ.M. PAQUIN More articles by this author , F. MAUFFETTEF. MAUFFETTE More articles by this author , R. FAUCHERR. FAUCHER More articles by this author , and J.P. PERREAULTJ.P. PERREAULT More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)68075-5AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We evaluate the long-term outcome of initial Ta grade 1 transitional cell carcinoma. Materials and Methods: A total of 152 patients with initial Ta grade 1 bladder tumor were followed for a mean of 76 months (range 6 to 241). Recurrence was defined as positive findings on cystoscopy or biopsy. Progression was defined as an increase in tumor grade or stage. Results: Tumor recurrence in 83 of 152 patients (55%) was noted within 12 months of followup in 38 patients (46%), between 12 and 24 in 11 (13%), and between 24 and 60 in 22 (27%). A significant number of recurrences (12, 14%) were diagnosed more than 60 months after the first tumor. Of 83 patients with recurrence 31 (37%) had progression, including 21 to grade 2 and 2 to grade 3 disease. Carcinoma in situ was diagnosed in 3 patients and 5 had muscle invasive disease. Progression occurred more than 24 months after initial diagnosis in 20 patients and more than 60 months after first tumor event (2 had carcinoma in situ and 2 had muscle invasive disease) in 12. Conclusions: Ta grade 1 bladder transitional cell carcinomas have a high recurrence rate and progression is not uncommon. These findings warrant close long-term followup, even when in some settings the trend is to discontinue followup after 5 years without any abnormal findings. References 1 : National Bladder Cancer Collaborative Group A: Superficial bladder cancer: progression and recurrence. J. Urol.1983; 130: 1083. Abstract, Google Scholar 2 : Long-term results of intravesical therapy for superficial bladder cancer. Urol. Clin. N. Amer.1992; 19: 573. Google Scholar 3 : Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. J. Clin. Oncol.1995; 13: 1404. Google Scholar 4 : Superficial bladder cancer: for how long should a tumor-free patient have check cystoscopies? Brit. J. Urol.1995; 75: 193. Google Scholar 5 : Longitudinal study of patients with bladder cancer: factors associated with disease recurrence and progression. In: . Baltimore: Williams & Wilkins1982: 35. Google Scholar 6 : Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. J. Urol.1983; 129: 730. Link, Google Scholar 7 : Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases. Brit. J. Urol.1986; 58: 659. Google Scholar 8 : Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J. Urol.1989; 142: 284. Link, Google Scholar 9 : Prognostic factors in superficial bladder cancer. A review. Eur. Urol.1992; 21: 89. Google Scholar 10 : Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir. Scand.1965; 130: 371. Google Scholar 11 : Epitheliomo of the genito-urinary organs. Ann. Surg.1922; 75: 574. Google Scholar 12 : Histological typing of urinary bladder tumours. International Histological Classification of Tumours, No. 10. Geneva: World Health Organization1973. Google Scholar 13 : Follow-up of patients with “superficial” transitional cell carcinoma of the bladder: the case for a change in policy. Brit. J. Urol.1993; 72: 135. Google Scholar 14 : The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J. Urol.1995; 153: 1823. Link, Google Scholar 15 : Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group. J. Urol.1992; 148: 1413. Link, Google Scholar 16 : Appropriate endpoints for superficial bladder cancer clinical trials. J. Clin. Oncol.1987; 5: 2004. Google Scholar 17 : The biology and treatment of superficial bladder cancer. J. Clin. Oncol.1984; 2: 505. Google Scholar 18 : Benign papilloma or papillary carcinoma of the bladder?. J. Urol.1973; 110: 205. Link, Google Scholar 19 : Local recurrence after cystectomy alone for bladder carcinoma. Cancer1992; 69: 2767. Google Scholar 20 : Late invasive recurrence despite long-term surveillance for superficial bladder cancer. J. Urol.1993; 149: 1010. Link, Google Scholar From the Division of Urology, CHUM-Campus St-Luc, Montréal, Québec, Canada© 1999 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byChang S, Boorjian S, Chou R, Clark P, Daneshmand S, Konety B, Pruthi R, Quale D, Ritch C, Seigne J, Skinner E, Smith N and McKiernan J (2018) Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO GuidelineJournal of Urology, VOL. 196, NO. 4, (1021-1029), Online publication date: 1-Oct-2016.Lamm D, Persad R, Brausi M, Buckley R, Witjes J, Palou J, Böhle A, Kamat A, Colombel M and Soloway M (2018) Defining Progression in Nonmuscle Invasive Bladder Cancer: It is Time for a New, Standard DefinitionJournal of Urology, VOL. 191, NO. 1, (20-27), Online publication date: 1-Jan-2014.Sabir E and Holmäng S (2018) TaG1 Bladder Cancer: A Third of All Primary Tumors and 80% of All Recurrences Can Be Treated in the Office Using Local AnesthesiaUrology Practice, VOL. 1, NO. 4, (184-188), Online publication date: 1-Nov-2014.Mariappan P, Smith G, Lamb A, Grigor K and Tolley D (2018) Pattern of Recurrence Changes in Noninvasive Bladder Tumors Observed During 2 DecadesJournal of Urology, VOL. 177, NO. 3, (867-875), Online publication date: 1-Mar-2007.MARIAPPAN P and SMITH G (2018) A SURVEILLANCE SCHEDULE FOR G1Ta BLADDER CANCER ALLOWING EFFICIENT USE OF CHECK CYSTOSCOPY AND SAFE DISCHARGE AT 5 YEARS BASED ON A 25-YEAR PROSPECTIVE DATABASEJournal of Urology, VOL. 173, NO. 4, (1108-1111), Online publication date: 1-Apr-2005.DONAT S, NORTH A, DALBAGNI G and HERR H (2018) Efficacy of Office Fulguration for Recurrent Low Grade Papillary Bladder Tumors Less Than 0.5 cmJournal of Urology, VOL. 171, NO. 2, (636-639), Online publication date: 1-Feb-2004.HERR H (2018) TUMOR PROGRESSION AND SURVIVAL OF PATIENTS WITH HIGH GRADE, NONINVASIVE PAPILLARY (TaG3) BLADDER TUMORS: 15-YEAR OUTCOMEJournal of Urology, VOL. 163, NO. 1, (60-62), Online publication date: 1-Jan-2000. Volume 162Issue 6December 1999Page: 1946-1950 Advertisement Copyright & Permissions© 1999 by American Urological Association, Inc.Keywordsprognosisbladder neoplasmscarcinoma, transitional cellMetricsAuthor Information B. LEBLANC More articles by this author A.J. DUCLOS More articles by this author F. BÉNARD More articles by this author J. CÔTÉ More articles by this author L. VALIQUETTE More articles by this author J.M. PAQUIN More articles by this author F. MAUFFETTE More articles by this author R. FAUCHER More articles by this author J.P. PERREAULT More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W2022195954 created "2016-06-24" @default.
• W2022195954 creator A5016388085 @default.
• W2022195954 creator A5022078827 @default.
• W2022195954 creator A5036914963 @default.
• W2022195954 creator A5040772609 @default.
• W2022195954 creator A5043076891 @default.
• W2022195954 creator A5068138589 @default.
• W2022195954 creator A5074161562 @default.
• W2022195954 creator A5080083095 @default.
• W2022195954 creator A5087317027 @default.
• W2022195954 date "1999-12-01" @default.
• W2022195954 modified "2023-10-14" @default.
• W2022195954 title "LONG-TERM FOLLOWUP OF INITIAL Ta GRADE 1 TRANSITIONAL CELL CARCINOMA OF THE BLADDER" @default.
• W2022195954 cites W1578797961 @default.
• W2022195954 cites W171038488 @default.
• W2022195954 cites W1781424562 @default.
• W2022195954 cites W2026553119 @default.
• W2022195954 cites W2029998105 @default.
• W2022195954 cites W2031977829 @default.
• W2022195954 cites W2033568891 @default.
• W2022195954 cites W2141338468 @default.
• W2022195954 cites W2222191055 @default.
• W2022195954 cites W2229398429 @default.
• W2022195954 cites W2402487223 @default.
• W2022195954 cites W2403630419 @default.
• W2022195954 cites W2405990584 @default.
• W2022195954 cites W2409863401 @default.
• W2022195954 cites W2411261141 @default.
• W2022195954 cites W2415472467 @default.
• W2022195954 cites W4245152549 @default.
• W2022195954 doi "https://doi.org/10.1016/s0022-5347(05)68075-5" @default.
• W2022195954 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10569544" @default.
• W2022195954 hasPublicationYear "1999" @default.
• W2022195954 type Work @default.
• W2022195954 sameAs 2022195954 @default.
• W2022195954 citedByCount "86" @default.
• W2022195954 countsByYear W20221959542012 @default.
• W2022195954 countsByYear W20221959542013 @default.
• W2022195954 countsByYear W20221959542014 @default.
• W2022195954 countsByYear W20221959542015 @default.
• W2022195954 countsByYear W20221959542016 @default.
• W2022195954 countsByYear W20221959542017 @default.
• W2022195954 countsByYear W20221959542018 @default.
• W2022195954 countsByYear W20221959542019 @default.
• W2022195954 countsByYear W20221959542020 @default.
• W2022195954 countsByYear W20221959542021 @default.
• W2022195954 countsByYear W20221959542022 @default.
• W2022195954 countsByYear W20221959542023 @default.
• W2022195954 crossrefType "journal-article" @default.
• W2022195954 hasAuthorship W2022195954A5016388085 @default.
• W2022195954 hasAuthorship W2022195954A5022078827 @default.
• W2022195954 hasAuthorship W2022195954A5036914963 @default.
• W2022195954 hasAuthorship W2022195954A5040772609 @default.
• W2022195954 hasAuthorship W2022195954A5043076891 @default.
• W2022195954 hasAuthorship W2022195954A5068138589 @default.
• W2022195954 hasAuthorship W2022195954A5074161562 @default.
• W2022195954 hasAuthorship W2022195954A5080083095 @default.
• W2022195954 hasAuthorship W2022195954A5087317027 @default.
• W2022195954 hasConcept C121332964 @default.
• W2022195954 hasConcept C121608353 @default.
• W2022195954 hasConcept C126322002 @default.
• W2022195954 hasConcept C126894567 @default.
• W2022195954 hasConcept C2777546739 @default.
• W2022195954 hasConcept C2778065480 @default.
• W2022195954 hasConcept C2780352672 @default.
• W2022195954 hasConcept C61797465 @default.
• W2022195954 hasConcept C62520636 @default.
• W2022195954 hasConcept C71924100 @default.
• W2022195954 hasConceptScore W2022195954C121332964 @default.
• W2022195954 hasConceptScore W2022195954C121608353 @default.
• W2022195954 hasConceptScore W2022195954C126322002 @default.
• W2022195954 hasConceptScore W2022195954C126894567 @default.
• W2022195954 hasConceptScore W2022195954C2777546739 @default.
• W2022195954 hasConceptScore W2022195954C2778065480 @default.
• W2022195954 hasConceptScore W2022195954C2780352672 @default.
• W2022195954 hasConceptScore W2022195954C61797465 @default.
• W2022195954 hasConceptScore W2022195954C62520636 @default.
• W2022195954 hasConceptScore W2022195954C71924100 @default.
• W2022195954 hasIssue "6" @default.
• W2022195954 hasLocation W20221959541 @default.
• W2022195954 hasLocation W20221959542 @default.
• W2022195954 hasOpenAccess W2022195954 @default.
• W2022195954 hasPrimaryLocation W20221959541 @default.
• W2022195954 hasRelatedWork W1991176685 @default.
• W2022195954 hasRelatedWork W2023520015 @default.
• W2022195954 hasRelatedWork W2085899929 @default.
• W2022195954 hasRelatedWork W2148656812 @default.
• W2022195954 hasRelatedWork W2151556292 @default.
• W2022195954 hasRelatedWork W2317368154 @default.
• W2022195954 hasRelatedWork W2369087181 @default.
• W2022195954 hasRelatedWork W2392413698 @default.
• W2022195954 hasRelatedWork W2472699578 @default.
• W2022195954 hasRelatedWork W2118673085 @default.
• W2022195954 hasVolume "162" @default.
• W2022195954 isParatext "false" @default.
• W2022195954 isRetracted "false" @default.
• W2022195954 magId "2022195954" @default.

• next